Pharmacotherapy for posttraumatic stress disorder: Review with clinical applications

Matthew Jeffreys, Bruce Capehart, Matthew J. Friedman

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Posttraumatic stress disorder (PTSD) is a prevalent psychiatric diagnosis among veterans and has high comorbidity with other medical and psychiatric conditions. This article reviews the pharmacotherapy recommendations from the 2010 revised Department of Veterans Affairs/Department of Defense Clinical Practice Guideline (CPG) for PTSD and provides practical PTSD treatment recommendations for clinicians. While evidence-based, trauma-focused psychotherapy is the preferred treatment for PTSD, pharmacotherapy is also an important treatment option. First-line pharmacotherapy agents include selective serotonin reuptake inhibitors and the selective serotonin-norepinephrine reuptake inhibitor venlafaxine. Second-line agents have less evidence for their usefulness in PTSD and carry a potentially greater side effect burden. They include nefazodone, mirtazapine, tricyclic antidepressants, and monoamine oxidase inhibitors. Prazosin is beneficial for nightmares. Benzodiazepines and antipsychotics, either as monotherapy or used adjunctively, are not recommended in the treatment of PTSD. Treating co-occurring disorders, such as major depressive disorder, substance use disorders, and traumatic brain injury, is essential in maximizing treatment outcomes in PTSD. The CPG provides evidence-based treatment recommendations for treating PTSD with and without such co-occurring disorders.

Original languageEnglish (US)
Pages (from-to)703-716
Number of pages14
JournalJournal of Rehabilitation Research and Development
Volume49
Issue number5
DOIs
StatePublished - 2012

Keywords

  • Best practices
  • Guidelines
  • Health services
  • Medica-tions
  • Mental health
  • Patient care
  • Pharmacotherapy
  • PTSD
  • Treatment
  • Veterans

ASJC Scopus subject areas

  • Rehabilitation

Fingerprint

Dive into the research topics of 'Pharmacotherapy for posttraumatic stress disorder: Review with clinical applications'. Together they form a unique fingerprint.

Cite this